Navigation Links
ValueOptions(R) Reinvests $3.1 Million in New Mexico
Date:6/25/2009

Mexico."

About ValueOptions(R), Inc.

ValueOptions(R), Inc., the nation's largest independent behavioral health and wellness company, provides services to more than 23 million individuals through a variety of contracts with state and county agencies and, additionally, with health plans and employers. ValueOptions(R) is a national behavioral health and wellness company that specializes in management for all behavioral health issues and promotes health and wellness through innovative programs. ValueOptions(R)' mission is to improve the health and wellness for the people it serves.


'/>"/>
SOURCE ValueOptions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ValueOptions(R) New Mexico Files Formal Protest of Award of New Mexico Behavioral Health Contract to United
2. NCQA Awards Accredited Status to ValueOptions(R) North Carolina Employer Solutions Service Center
3. ValueOptions(R) Enters Agreement with CareIntegra to Provide Integrated Health Services
4. ValueOptions(R) Behavioral Health and Wellness Web Site Wins eHealthcare Leadership Award for Best Site Design Second Year in a Row
5. Future of Behavioral Health Care for New Mexicos Youth Subject of Expert Panel Sponsored by ValueOptions(R)
6. ValueOptions(R) New Mexico Provides $10.3 Million for Community Behavioral Health Care Organizations
7. Give an Hour(TM)s Volunteer Mental Health Professionals Provide More Than $1.4 Million in Services to Iraq and Afghanistan Veterans, Families, and Communities
8. IncentOne Achieves 2 Millionth Health Milestone
9. CHRISTUS Health New Mexico Region Focuses on Cost Management; Saves $1.8 Million
10. Toyota Awards $1 Million in Scholarships to 100 High School Seniors - Roslyn Highs Urbach Named One of Only 12 National Winners; Receives $20,000
11. Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... essential fatty acids commonly found in fatty fish ... to research published by the American Psychological Association. ... problems found in people with schizophrenia; bipolar, obsessive-compulsive, ... afflictions of the nervous system. , The ... , provides more evidence that fish is brain ...
(Date:12/16/2009)... cut bleeding time in half, but use in humans is ... Hoping to improve on nature, researchers have built and tested ... used in trauma or other cases where blood just won,t ... material that is used in degradable stitches, which dissolve in ... engineering at Case Western Reserve University, and lead author of ...
(Date:12/16/2009)... Neurological Stress Reduction Therapy or NSRTSM is found very effective ... such as allergies, asthma, migraines, chronic fatigue and a wide ... the country are using this holistic therapy including over 50 ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda ...
(Date:12/16/2009)... government report finds , , WEDNESDAY, Dec. 16 (HealthDay News) ... 45.4 million Americans of all ages -- or 15.1 ... according to new National Health Interview Survey statistics released ... of all ages had been uninsured for at least ... 31.9 million (10.6 percent) had been uninsured for more ...
(Date:12/16/2009)... Dec. 16 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced Alison ... the UK. Ms. Davies has spent the ... the dental industry, most recently for nine years ... , makers of Invisalign . ...
Breaking Medicine News(10 mins):Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4
... Accelerate Manufacture of Clinical Trial ... Pharmaceuticals, ... Michigan company specializing in winning FDA approval,for new drugs and medical ... award. RAA received the award for its development,of a fast-track process ...
... NATICK, Mass., Oct. 17 Boston Scientific,Corporation ... initiatives designed to,enhance short- and long-term shareholder value, ... as well as substantial expense and head,count reductions ... The,Company also said it is making good progress ...
... Oct. 17 GenPrime, Inc. a leading,provider of ... of its Bacterial Contamination Test for Platelets(TM). The,test ... presence of aerobic and,anaerobic bacteria commonly found in ... a 510 (K) pre-market notification with the Food,and ...
... ,Haemonetics Corporation (NYSE: HAE ) is pleased ... effective October 22, 2007 as President,Haemonetics Japan. Ms. ... who previously announced plans to retire. Brian ... tremendous experience and a proven track record for ...
... Address FDA,s Next Big Challenge, WASHINGTON, Oct. 17 ... information on drugs,and devices to physicians and the public?, ... will discuss and debate at a,landmark Colloquium, Communicating Risk/Safety ... Food and Drug Law Institute (FDLI),Dec. 6, 2007, in ...
... Kyphon Inc.,(Nasdaq: KYPH ) today announced ... and the Foundation for Osteoporosis Research,and Education (FORE) ... during World Osteoporosis Day on Saturday, October 20, ... go to: http://www.prnewswire.com/mnr/kyphon/29938/ To ...
Other Medicine News:Health News:Regulatory Affairs Associates Gets New Drugs Tested Faster, Wins 2007 Innovation Michigan Award 2Health News:Boston Scientific Announces New Initiatives to Increase Shareholder Value 2Health News:Boston Scientific Announces New Initiatives to Increase Shareholder Value 3Health News:Boston Scientific Announces New Initiatives to Increase Shareholder Value 4Health News:Boston Scientific Announces New Initiatives to Increase Shareholder Value 5Health News:GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets 2Health News:Keiko Hattori Joins Haemonetics as President of Haemonetics Japan 2Health News:Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information 2Health News:Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk 2Health News:Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk 3
(Date:12/16/2009)... Vote Against Lower Prescription Drug Prices ,, ... on Tuesday night rejected an amendment to the ... help make prescription drugs more affordable by allowing ... priced drugs from abroad. The bipartisan amendment, ... Snowe, McCain, Grassley and Stabenow, would have improved ...
(Date:12/16/2009)... Dec. 16 Frost & Sullivan,s ... looks forward to speaking at the 2010 ... place on January 9, 2010 in Las ... emerging market of consumer-based digital health and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch focuses ...
(Date:12/16/2009)... Savara, Inc., an inhalation drug delivery company, today announced ... Series A financing round, exceeding the targeted total raise ... in the Series A round will be utilized to ... "We now have the runway and resources to effectively ... said Rob Neville, CEO of Savara. ,, The ...
Breaking Medicine Technology:AARP Illinois Key Vote News Alert 2Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2China Sky One Medical Inc Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 15016 1China Sky One Medical Inc Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 15016 2China Sky One Medical Inc Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 15016 3BioSpec Global Solutions Inc contracts with RMF Design 26amp 3B Manufacturing Inc for production of the TOGs 3000 and 9000 units for U S market 15014 1CryoLife Provides Initial 2010 Financial Guidance 6633 1CryoLife Provides Initial 2010 Financial Guidance 6633 2CryoLife Provides Initial 2010 Financial Guidance 6633 3CryoLife Provides Initial 2010 Financial Guidance 6633 4CryoLife Provides Initial 2010 Financial Guidance 6633 5
... Week(R) 2008, NATICK, Mass. and SAN DIEGO, ... ) today announced results from an,international, multi-center patient ... its SpyGlass(R) Direct Visualization System,which offers extensive visual ... were presented by Yang K. Chen, M.D., Division ...
... Men Maintained Normal Testosterone Levels Throughout ... ... of Men Expressed Satisfaction with NEBIDO, LEXINGTON, Mass., May 20 ... undecanoate), an investigational, long-acting intramuscular,injection for the treatment of hypogonadism, was presented ...
Other Medicine Technology:Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 2Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 3Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 4Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 5Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 2Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 3Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 4
Enzyme Immunoassay for the Quantitative Measurement of Ovarian Cancer Antigen CA-125 in Human Serum...
Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....
... BrainSUITE iMRI is a neurosurgical OR ... and diagnostic tools, including iMRI, necessary ... BrainSUITE iMRI, neurosurgical treatments are performed ... and designed for MR compatibility and ...
... Quality EEG recording is assured even ... Neurofax has high performance, high sensitivity ... ECG rejection filter, shielded electrodes and a ... connection. Neurofax is a complete and ...
Medicine Products: